Reduction of severity of chemotherapy-induced peripheral neuropathy by OnLife®14.02.2020 Final results of the breast cancer cohort of the STEFANO trial. 20. Februar 2020 Zaiss, M., Uhlig, J., Zahn, M.-O., Decker, T., Lehmann, H., Harde, J., Hogrefe, C., Vannier, C., Marschner, N., 2020. Oncol Res Treat 43 (suppl 1)(405), 185. Palbociclib plus fulvestrant as second- or later-line therapy for patients with locally advanced, inoperable or metastatic HR+/HER2- breast cancer in Germany: Interim results of the INGE-B phase 2 study. Lüftner, D., Welslau, M., Liersch, R., Deryal, M., Brucker, C., Rauh, J., Welt, A., Zaiss, M., Houet, L., Vannier, C., Potthoff, K., Marschner, N., 2020. Weiterlesen Routine care of advanced breast cancer: the prospective, national research platform OPAL for patients with advanced breast cancer in Germany. Decker T., Harbeck N., Thill M., Zahn M.-O., Nusch A., Lorenz A., Söling U., Chiabudini M., Kruggel L., Jänicke M., Marschner N., Stickeler E., Wöckel… Weiterlesen